Spikes in demand from coronavirus patients are creating shortages of asthma drugs and sedatives for ventilator patients

The United States is heavily dependent on foreign suppliers for drugs and raw pharmaceutical ingredients, but the FDA has blind spots in the global supply chain. New powers it just won from Congress don’t start until September.

Leave a Reply

%d bloggers like this: